| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder, Neurogenic | 48 | 2024 | 174 | 7.750 |
Why?
|
| Urodynamics | 70 | 2024 | 350 | 7.140 |
Why?
|
| Urinary Bladder | 63 | 2023 | 1170 | 4.810 |
Why?
|
| Urinary Incontinence | 36 | 2021 | 492 | 3.510 |
Why?
|
| Intermittent Urethral Catheterization | 4 | 2023 | 13 | 3.120 |
Why?
|
| Urination Disorders | 22 | 2018 | 242 | 2.760 |
Why?
|
| Urinary Tract | 21 | 2023 | 309 | 2.560 |
Why?
|
| Meningomyelocele | 22 | 2012 | 164 | 2.380 |
Why?
|
| Urethra | 32 | 2020 | 404 | 2.190 |
Why?
|
| Vesico-Ureteral Reflux | 39 | 2022 | 438 | 1.960 |
Why?
|
| Urinary Bladder Diseases | 17 | 2016 | 170 | 1.560 |
Why?
|
| Urologic Diseases | 7 | 2016 | 247 | 1.510 |
Why?
|
| Neural Tube Defects | 12 | 2017 | 253 | 1.500 |
Why?
|
| Botulinum Toxins, Type A | 4 | 2024 | 224 | 1.470 |
Why?
|
| Spinal Dysraphism | 7 | 2024 | 172 | 1.440 |
Why?
|
| Urogenital Abnormalities | 9 | 2022 | 255 | 1.250 |
Why?
|
| Urology | 7 | 2024 | 421 | 1.200 |
Why?
|
| Nocturnal Enuresis | 4 | 2019 | 12 | 1.070 |
Why?
|
| Urinary Bladder, Overactive | 5 | 2021 | 114 | 1.050 |
Why?
|
| Diagnostic Techniques, Urological | 4 | 2015 | 28 | 1.050 |
Why?
|
| Fecal Incontinence | 5 | 2015 | 242 | 1.020 |
Why?
|
| Neuromuscular Agents | 3 | 2024 | 143 | 0.940 |
Why?
|
| Child | 175 | 2024 | 79427 | 0.920 |
Why?
|
| Ureter | 15 | 2016 | 378 | 0.890 |
Why?
|
| Urinary Tract Infections | 15 | 2023 | 814 | 0.860 |
Why?
|
| Urinary Catheterization | 12 | 2023 | 202 | 0.710 |
Why?
|
| Urination | 13 | 2022 | 204 | 0.680 |
Why?
|
| Losartan | 1 | 2021 | 259 | 0.660 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2021 | 438 | 0.600 |
Why?
|
| Defecation | 3 | 2017 | 190 | 0.570 |
Why?
|
| Child, Preschool | 110 | 2024 | 41893 | 0.560 |
Why?
|
| Constipation | 5 | 2015 | 555 | 0.550 |
Why?
|
| Terminology as Topic | 5 | 2015 | 1532 | 0.500 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 595 | 0.490 |
Why?
|
| Spinal Cord | 11 | 2017 | 1808 | 0.480 |
Why?
|
| Urologic Surgical Procedures | 6 | 2024 | 308 | 0.450 |
Why?
|
| Fibrosis | 1 | 2021 | 2018 | 0.450 |
Why?
|
| Cerebral Palsy | 3 | 2017 | 472 | 0.450 |
Why?
|
| Varicocele | 6 | 2015 | 78 | 0.430 |
Why?
|
| Urethral Diseases | 4 | 2018 | 53 | 0.430 |
Why?
|
| Infant | 85 | 2020 | 35867 | 0.420 |
Why?
|
| Neurogenic Bowel | 1 | 2012 | 1 | 0.420 |
Why?
|
| Ureteral Obstruction | 11 | 2011 | 294 | 0.420 |
Why?
|
| Digestive System Abnormalities | 1 | 2012 | 49 | 0.400 |
Why?
|
| Glycopeptides | 1 | 2013 | 220 | 0.400 |
Why?
|
| Syringomyelia | 1 | 2012 | 67 | 0.390 |
Why?
|
| Humans | 231 | 2024 | 755533 | 0.390 |
Why?
|
| Writing | 1 | 2013 | 200 | 0.380 |
Why?
|
| Kidney | 23 | 2022 | 7009 | 0.380 |
Why?
|
| Biofeedback, Psychology | 2 | 2009 | 115 | 0.380 |
Why?
|
| Urography | 11 | 2016 | 314 | 0.380 |
Why?
|
| Adolescent | 93 | 2024 | 87236 | 0.370 |
Why?
|
| Antidiuretic Agents | 2 | 2012 | 23 | 0.370 |
Why?
|
| Consensus | 7 | 2024 | 3057 | 0.360 |
Why?
|
| Intestines | 5 | 2017 | 1901 | 0.360 |
Why?
|
| Deamino Arginine Vasopressin | 2 | 2012 | 88 | 0.360 |
Why?
|
| Mandelic Acids | 4 | 1999 | 46 | 0.360 |
Why?
|
| Urinary Sphincter, Artificial | 2 | 2008 | 23 | 0.350 |
Why?
|
| Pediatrics | 5 | 2024 | 3582 | 0.330 |
Why?
|
| Quality of Life | 5 | 2017 | 13201 | 0.330 |
Why?
|
| Diverticulum | 4 | 2009 | 138 | 0.330 |
Why?
|
| Self Concept | 1 | 2015 | 1027 | 0.330 |
Why?
|
| Male | 161 | 2024 | 356577 | 0.320 |
Why?
|
| Hydronephrosis | 15 | 2011 | 272 | 0.320 |
Why?
|
| Kidney Pelvis | 4 | 2017 | 188 | 0.310 |
Why?
|
| Hypospadias | 8 | 2001 | 98 | 0.310 |
Why?
|
| Infant, Newborn | 52 | 2018 | 26039 | 0.300 |
Why?
|
| Intestine, Small | 1 | 2014 | 1201 | 0.300 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 3440 | 0.290 |
Why?
|
| Cholinergic Antagonists | 4 | 2003 | 164 | 0.290 |
Why?
|
| Tissue Engineering | 3 | 2014 | 1861 | 0.290 |
Why?
|
| Pressure | 6 | 2018 | 1149 | 0.280 |
Why?
|
| Fetus | 3 | 2012 | 1887 | 0.280 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 1391 | 0.280 |
Why?
|
| Patient Compliance | 4 | 2015 | 2684 | 0.280 |
Why?
|
| Urethral Stricture | 3 | 2017 | 51 | 0.280 |
Why?
|
| Toilet Training | 2 | 2019 | 18 | 0.270 |
Why?
|
| Fetal Diseases | 2 | 2011 | 912 | 0.270 |
Why?
|
| Enuresis | 4 | 2006 | 50 | 0.260 |
Why?
|
| Testis | 7 | 2015 | 792 | 0.260 |
Why?
|
| Female | 129 | 2024 | 387920 | 0.260 |
Why?
|
| Bladder Exstrophy | 4 | 2014 | 106 | 0.250 |
Why?
|
| Bulbourethral Glands | 1 | 2004 | 7 | 0.250 |
Why?
|
| Spina Bifida Occulta | 4 | 2000 | 31 | 0.240 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 2304 | 0.240 |
Why?
|
| Sacrum | 5 | 2012 | 280 | 0.240 |
Why?
|
| Postoperative Complications | 20 | 2011 | 15576 | 0.240 |
Why?
|
| Urinary Diversion | 10 | 2003 | 135 | 0.240 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 2606 | 0.230 |
Why?
|
| Genital Diseases, Male | 1 | 2004 | 83 | 0.230 |
Why?
|
| Muscle, Smooth | 5 | 2015 | 923 | 0.230 |
Why?
|
| Adolescent Behavior | 1 | 2012 | 1182 | 0.220 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3001 | 0.220 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2278 | 0.210 |
Why?
|
| Meningocele | 3 | 2016 | 45 | 0.200 |
Why?
|
| Ureteral Neoplasms | 1 | 2003 | 111 | 0.200 |
Why?
|
| Periodicals as Topic | 1 | 2013 | 1457 | 0.200 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2010 | 906 | 0.200 |
Why?
|
| Pedigree | 8 | 2020 | 4577 | 0.200 |
Why?
|
| Polyps | 2 | 2003 | 198 | 0.200 |
Why?
|
| Reproducibility of Results | 9 | 2022 | 19987 | 0.200 |
Why?
|
| Electromyography | 18 | 2020 | 1378 | 0.190 |
Why?
|
| Caregivers | 2 | 2023 | 2190 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2024 | 804 | 0.180 |
Why?
|
| Clinical Protocols | 2 | 2016 | 1436 | 0.180 |
Why?
|
| Ureterostomy | 1 | 2000 | 18 | 0.180 |
Why?
|
| Cystostomy | 1 | 2000 | 25 | 0.180 |
Why?
|
| Retrospective Studies | 36 | 2024 | 79686 | 0.180 |
Why?
|
| Urologic Surgical Procedures, Male | 3 | 2017 | 76 | 0.180 |
Why?
|
| Urinary Bladder Neck Obstruction | 2 | 2000 | 81 | 0.180 |
Why?
|
| Spasm | 1 | 2000 | 133 | 0.170 |
Why?
|
| Young Adult | 14 | 2022 | 58025 | 0.170 |
Why?
|
| Ketorolac | 1 | 2000 | 93 | 0.170 |
Why?
|
| Cysts | 2 | 2004 | 685 | 0.170 |
Why?
|
| Video Recording | 3 | 2015 | 945 | 0.170 |
Why?
|
| Hospitals, Pediatric | 5 | 2024 | 1847 | 0.160 |
Why?
|
| Solanaceous Alkaloids | 1 | 2018 | 3 | 0.160 |
Why?
|
| Fraser Syndrome | 1 | 2018 | 5 | 0.160 |
Why?
|
| Orchiopexy | 1 | 2017 | 20 | 0.150 |
Why?
|
| Fatty Acids, Volatile | 1 | 2018 | 99 | 0.150 |
Why?
|
| Follow-Up Studies | 31 | 2019 | 39179 | 0.150 |
Why?
|
| Eye Abnormalities | 1 | 2020 | 243 | 0.150 |
Why?
|
| Sacrococcygeal Region | 2 | 2016 | 54 | 0.150 |
Why?
|
| Parasympatholytics | 3 | 1994 | 88 | 0.150 |
Why?
|
| Genetic Linkage | 3 | 2012 | 2385 | 0.140 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2018 | 176 | 0.140 |
Why?
|
| Urethral Obstruction | 1 | 1997 | 55 | 0.140 |
Why?
|
| Rheology | 1 | 2018 | 346 | 0.140 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2019 | 269 | 0.140 |
Why?
|
| Urinary Reservoirs, Continent | 4 | 1998 | 29 | 0.140 |
Why?
|
| Mutation | 5 | 2020 | 29807 | 0.140 |
Why?
|
| Receptors, Nicotinic | 1 | 2019 | 497 | 0.130 |
Why?
|
| Cystoscopy | 6 | 2011 | 135 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 2 | 2020 | 1597 | 0.130 |
Why?
|
| Kidney Diseases | 7 | 2012 | 2061 | 0.130 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2018 | 167 | 0.130 |
Why?
|
| Societies, Medical | 4 | 2015 | 3856 | 0.130 |
Why?
|
| Diurnal Enuresis | 1 | 2015 | 3 | 0.130 |
Why?
|
| Urinary Incontinence, Urge | 3 | 2015 | 50 | 0.130 |
Why?
|
| Muscle Weakness | 1 | 2018 | 412 | 0.120 |
Why?
|
| Disease Management | 2 | 2016 | 2484 | 0.120 |
Why?
|
| Age Factors | 7 | 2015 | 18366 | 0.120 |
Why?
|
| Sports | 1 | 2021 | 693 | 0.120 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 15197 | 0.120 |
Why?
|
| Urinary Tract Physiological Phenomena | 1 | 2014 | 11 | 0.120 |
Why?
|
| Stomach | 4 | 2000 | 696 | 0.120 |
Why?
|
| Tretinoin | 1 | 2017 | 523 | 0.120 |
Why?
|
| Self Care | 4 | 2012 | 789 | 0.110 |
Why?
|
| Spinal Cord Injuries | 4 | 2008 | 920 | 0.110 |
Why?
|
| Sperm Motility | 1 | 2015 | 266 | 0.110 |
Why?
|
| Abnormalities, Multiple | 4 | 2016 | 1419 | 0.110 |
Why?
|
| Students | 1 | 2023 | 1704 | 0.110 |
Why?
|
| Social Participation | 1 | 2015 | 182 | 0.110 |
Why?
|
| Semen Analysis | 1 | 2015 | 230 | 0.110 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 504 | 0.110 |
Why?
|
| T-Box Domain Proteins | 1 | 2015 | 463 | 0.110 |
Why?
|
| Treatment Outcome | 21 | 2016 | 64535 | 0.110 |
Why?
|
| Cryptorchidism | 3 | 1999 | 126 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2016 | 8487 | 0.100 |
Why?
|
| Genes, Dominant | 1 | 2015 | 865 | 0.100 |
Why?
|
| Social Adjustment | 1 | 2015 | 633 | 0.100 |
Why?
|
| Anal Canal | 2 | 2012 | 371 | 0.100 |
Why?
|
| Ureterocele | 3 | 2001 | 28 | 0.100 |
Why?
|
| Urinary Calculi | 3 | 2001 | 91 | 0.100 |
Why?
|
| Time Factors | 16 | 2016 | 39961 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2012 | 410 | 0.100 |
Why?
|
| Parents | 2 | 2022 | 3530 | 0.090 |
Why?
|
| Genes, X-Linked | 1 | 2011 | 128 | 0.090 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 3 | 2000 | 83 | 0.090 |
Why?
|
| Pain | 3 | 2020 | 4999 | 0.090 |
Why?
|
| Enema | 1 | 2011 | 140 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 7434 | 0.090 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1991 | 172 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2000 | 2270 | 0.090 |
Why?
|
| Rectum | 2 | 2012 | 896 | 0.090 |
Why?
|
| Administration, Intravesical | 2 | 2004 | 91 | 0.090 |
Why?
|
| Death, Sudden | 1 | 2012 | 306 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2018 | 2561 | 0.090 |
Why?
|
| Infant Care | 1 | 2011 | 180 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 8167 | 0.080 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 25696 | 0.080 |
Why?
|
| Prognosis | 6 | 2019 | 29423 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2020 | 2974 | 0.080 |
Why?
|
| Muscarinic Antagonists | 3 | 2015 | 136 | 0.080 |
Why?
|
| Adult | 42 | 2021 | 217986 | 0.080 |
Why?
|
| Kidney Calices | 1 | 2009 | 26 | 0.080 |
Why?
|
| Testicular Hydrocele | 1 | 2008 | 27 | 0.080 |
Why?
|
| Neurologic Examination | 5 | 1997 | 910 | 0.080 |
Why?
|
| International Cooperation | 1 | 2015 | 1427 | 0.080 |
Why?
|
| Rupture, Spontaneous | 2 | 2004 | 352 | 0.080 |
Why?
|
| Rats | 5 | 2021 | 23588 | 0.080 |
Why?
|
| Disease Progression | 3 | 2017 | 13427 | 0.080 |
Why?
|
| Spermatic Cord Torsion | 2 | 2005 | 73 | 0.080 |
Why?
|
| Urachus | 2 | 1998 | 18 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2012 | 15682 | 0.080 |
Why?
|
| Combined Modality Therapy | 5 | 2018 | 8555 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2009 | 384 | 0.080 |
Why?
|
| Urolithiasis | 1 | 2009 | 132 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2018 | 3596 | 0.070 |
Why?
|
| Nomograms | 1 | 2009 | 239 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3720 | 0.070 |
Why?
|
| Kidney Neoplasms | 2 | 2003 | 4307 | 0.070 |
Why?
|
| Physical Examination | 3 | 2012 | 1240 | 0.070 |
Why?
|
| Sperm Count | 1 | 2007 | 228 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2900 | 0.070 |
Why?
|
| Eosinophilia | 1 | 1991 | 556 | 0.070 |
Why?
|
| Risk Factors | 9 | 2021 | 73860 | 0.070 |
Why?
|
| Creatinine | 1 | 2012 | 1899 | 0.070 |
Why?
|
| Balanitis | 1 | 2005 | 3 | 0.070 |
Why?
|
| Choristoma | 2 | 1998 | 210 | 0.070 |
Why?
|
| Remission, Spontaneous | 3 | 2009 | 382 | 0.070 |
Why?
|
| Endoscopy | 3 | 2017 | 1839 | 0.060 |
Why?
|
| Testicular Diseases | 1 | 2005 | 73 | 0.060 |
Why?
|
| Benchmarking | 1 | 2012 | 1039 | 0.060 |
Why?
|
| Laparoscopy | 3 | 2008 | 2152 | 0.060 |
Why?
|
| Scrotum | 3 | 2005 | 116 | 0.060 |
Why?
|
| Anxiety | 1 | 2020 | 4484 | 0.060 |
Why?
|
| Sensitivity and Specificity | 4 | 2018 | 14636 | 0.060 |
Why?
|
| Ultrasonography | 7 | 2022 | 5937 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2016 | 2503 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2015 | 5180 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 17703 | 0.060 |
Why?
|
| Pyelonephritis | 4 | 1980 | 75 | 0.060 |
Why?
|
| Prostheses and Implants | 3 | 1991 | 1272 | 0.060 |
Why?
|
| Sympathomimetics | 1 | 2003 | 56 | 0.060 |
Why?
|
| Prosthesis Failure | 2 | 2008 | 1216 | 0.060 |
Why?
|
| Heterozygote | 2 | 2020 | 2788 | 0.060 |
Why?
|
| Microsurgery | 1 | 2008 | 781 | 0.050 |
Why?
|
| Observer Variation | 1 | 2009 | 2593 | 0.050 |
Why?
|
| Evidence-Based Medicine | 2 | 2012 | 3686 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2011 | 2270 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2022 | 10 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9561 | 0.050 |
Why?
|
| Radiography | 13 | 1997 | 6975 | 0.050 |
Why?
|
| Lipoma | 2 | 1997 | 291 | 0.050 |
Why?
|
| Teratoma | 1 | 2006 | 403 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2022 | 64 | 0.050 |
Why?
|
| Spinal Cord Diseases | 2 | 1988 | 289 | 0.050 |
Why?
|
| Injections, Intramuscular | 1 | 2024 | 555 | 0.050 |
Why?
|
| Spinal Cord Neoplasms | 2 | 1997 | 265 | 0.050 |
Why?
|
| Motor Neurons | 5 | 1995 | 851 | 0.050 |
Why?
|
| Prosthesis Design | 2 | 2008 | 2125 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5784 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18027 | 0.050 |
Why?
|
| Circumcision, Male | 2 | 2017 | 148 | 0.050 |
Why?
|
| Sex Factors | 4 | 2012 | 10493 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 1983 | 0.050 |
Why?
|
| Replantation | 3 | 1980 | 140 | 0.050 |
Why?
|
| Reference Standards | 2 | 2015 | 1005 | 0.050 |
Why?
|
| Rhabdomyosarcoma | 2 | 1996 | 359 | 0.050 |
Why?
|
| Amphibian Proteins | 1 | 2020 | 36 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 617 | 0.050 |
Why?
|
| Radiopharmaceuticals | 3 | 2000 | 2669 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2020 | 12073 | 0.050 |
Why?
|
| Lithotripsy | 1 | 2001 | 147 | 0.050 |
Why?
|
| Animals | 10 | 2021 | 167149 | 0.050 |
Why?
|
| Analysis of Variance | 4 | 2012 | 6237 | 0.050 |
Why?
|
| Incidence | 6 | 2018 | 21239 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 7342 | 0.040 |
Why?
|
| Home Nursing | 2 | 1998 | 92 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2016 | 3779 | 0.040 |
Why?
|
| Epispadias | 1 | 1999 | 19 | 0.040 |
Why?
|
| Digestive System | 1 | 2000 | 244 | 0.040 |
Why?
|
| Arabs | 1 | 2021 | 183 | 0.040 |
Why?
|
| Umbilical Arteries | 2 | 1978 | 79 | 0.040 |
Why?
|
| Reoperation | 6 | 2009 | 4283 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 2 | 2013 | 610 | 0.040 |
Why?
|
| Larva | 1 | 2020 | 511 | 0.040 |
Why?
|
| Phenotype | 4 | 2020 | 16478 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2017 | 23278 | 0.040 |
Why?
|
| Disorders of Sex Development | 1 | 1999 | 129 | 0.040 |
Why?
|
| Xenopus | 1 | 2020 | 712 | 0.040 |
Why?
|
| Electrophysiology | 4 | 1997 | 1264 | 0.040 |
Why?
|
| Chondrocytes | 1 | 2003 | 791 | 0.040 |
Why?
|
| Genetic Counseling | 2 | 1979 | 619 | 0.040 |
Why?
|
| Severity of Illness Index | 5 | 2015 | 15746 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2018 | 1735 | 0.040 |
Why?
|
| Urogenital System | 1 | 2018 | 88 | 0.040 |
Why?
|
| Gestational Age | 1 | 2006 | 3557 | 0.040 |
Why?
|
| DNA | 2 | 2003 | 7225 | 0.040 |
Why?
|
| Vaginal Diseases | 1 | 1998 | 104 | 0.040 |
Why?
|
| Prospective Studies | 7 | 2020 | 53991 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2017 | 36042 | 0.030 |
Why?
|
| Exons | 2 | 2018 | 2388 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 1978 | 181 | 0.030 |
Why?
|
| Nervous System | 1 | 2000 | 540 | 0.030 |
Why?
|
| Methods | 5 | 1990 | 1077 | 0.030 |
Why?
|
| Genome, Human | 1 | 2009 | 4407 | 0.030 |
Why?
|
| Kyphosis | 1 | 1998 | 237 | 0.030 |
Why?
|
| Chromosome Mapping | 3 | 2011 | 4629 | 0.030 |
Why?
|
| Reflex, Abnormal | 2 | 1994 | 82 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2003 | 1115 | 0.030 |
Why?
|
| Ileum | 3 | 1989 | 557 | 0.030 |
Why?
|
| Vaginal Neoplasms | 1 | 1996 | 106 | 0.030 |
Why?
|
| Ureteral Diseases | 2 | 1989 | 65 | 0.030 |
Why?
|
| Consanguinity | 1 | 2018 | 454 | 0.030 |
Why?
|
| Cystitis | 3 | 1994 | 96 | 0.030 |
Why?
|
| Lumbosacral Plexus | 1 | 1995 | 50 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2018 | 23956 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2015 | 174 | 0.030 |
Why?
|
| Mice | 6 | 2020 | 80745 | 0.030 |
Why?
|
| Perineum | 1 | 1996 | 210 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 296 | 0.030 |
Why?
|
| Urinary Fistula | 1 | 1994 | 43 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2002 | 1744 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2018 | 1165 | 0.030 |
Why?
|
| Cutaneous Fistula | 1 | 1994 | 80 | 0.030 |
Why?
|
| Nephrology | 1 | 2017 | 236 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1996 | 388 | 0.030 |
Why?
|
| Botulinum Toxins | 1 | 2015 | 189 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2013 | 20404 | 0.030 |
Why?
|
| Hypertrophy | 2 | 2007 | 556 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2868 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 827 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2018 | 2755 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3675 | 0.030 |
Why?
|
| Athletes | 1 | 2021 | 1101 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2292 | 0.030 |
Why?
|
| Boston | 4 | 2017 | 9254 | 0.030 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2015 | 185 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 1785 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 1064 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14330 | 0.030 |
Why?
|
| China | 1 | 2019 | 2337 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 880 | 0.030 |
Why?
|
| Prevalence | 2 | 2021 | 15589 | 0.030 |
Why?
|
| Behavior Therapy | 2 | 2013 | 860 | 0.030 |
Why?
|
| Diagnosis, Differential | 5 | 2011 | 12926 | 0.030 |
Why?
|
| Nervous System Diseases | 2 | 1996 | 1627 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 2667 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2015 | 986 | 0.030 |
Why?
|
| Laxatives | 1 | 2013 | 88 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3469 | 0.030 |
Why?
|
| Prenatal Diagnosis | 2 | 2017 | 1270 | 0.020 |
Why?
|
| Rhombencephalon | 1 | 2012 | 82 | 0.020 |
Why?
|
| Cicatrix | 2 | 2012 | 778 | 0.020 |
Why?
|
| Ostomy | 1 | 2011 | 29 | 0.020 |
Why?
|
| Models, Animal | 1 | 2018 | 2117 | 0.020 |
Why?
|
| Age Distribution | 1 | 1997 | 2887 | 0.020 |
Why?
|
| Clinical Alarms | 1 | 2012 | 61 | 0.020 |
Why?
|
| Surgical Stomas | 1 | 2011 | 42 | 0.020 |
Why?
|
| Surgical Wound Dehiscence | 1 | 1992 | 216 | 0.020 |
Why?
|
| Sleep Apnea, Central | 1 | 2012 | 88 | 0.020 |
Why?
|
| Logistic Models | 2 | 2015 | 13315 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4488 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2012 | 186 | 0.020 |
Why?
|
| Genital Neoplasms, Male | 1 | 1990 | 68 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2013 | 464 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 6890 | 0.020 |
Why?
|
| Prolapse | 1 | 1990 | 63 | 0.020 |
Why?
|
| Recurrence | 4 | 2011 | 8441 | 0.020 |
Why?
|
| Electrolytes | 1 | 2011 | 281 | 0.020 |
Why?
|
| Catheterization | 1 | 1975 | 1430 | 0.020 |
Why?
|
| Constriction, Pathologic | 2 | 2011 | 1105 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 12491 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1975 | 588 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 3 | 1989 | 1635 | 0.020 |
Why?
|
| Mesencephalon | 1 | 2012 | 329 | 0.020 |
Why?
|
| Organ Size | 1 | 2015 | 2250 | 0.020 |
Why?
|
| Base Sequence | 2 | 2015 | 12444 | 0.020 |
Why?
|
| Family | 1 | 2020 | 3181 | 0.020 |
Why?
|
| Contrast Media | 1 | 2022 | 5293 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2015 | 41119 | 0.020 |
Why?
|
| Dilatation, Pathologic | 4 | 1989 | 518 | 0.020 |
Why?
|
| Lod Score | 1 | 2009 | 602 | 0.020 |
Why?
|
| Risk | 4 | 1984 | 9624 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2011 | 598 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9310 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2012 | 776 | 0.020 |
Why?
|
| Netherlands | 1 | 2013 | 2204 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2667 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 17611 | 0.020 |
Why?
|
| Reflex | 1 | 1989 | 371 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2018 | 5417 | 0.020 |
Why?
|
| Siblings | 1 | 2011 | 826 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2931 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2004 | 7828 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 2011 | 495 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 2012 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2020 | 21907 | 0.020 |
Why?
|
| Ischemia | 1 | 1995 | 1892 | 0.020 |
Why?
|
| Radionuclide Imaging | 3 | 2000 | 1978 | 0.020 |
Why?
|
| Pregnancy | 3 | 2003 | 29543 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2012 | 748 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2000 | 12348 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4233 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 13434 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 1994 | 1661 | 0.020 |
Why?
|
| Psychometrics | 1 | 2015 | 3027 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 1180 | 0.020 |
Why?
|
| Scoliosis | 1 | 2012 | 726 | 0.020 |
Why?
|
| Walking | 1 | 1992 | 1176 | 0.020 |
Why?
|
| Postoperative Period | 2 | 2006 | 1820 | 0.020 |
Why?
|
| Thymine | 1 | 2004 | 69 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4722 | 0.010 |
Why?
|
| Infertility, Male | 1 | 2007 | 395 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2006 | 449 | 0.010 |
Why?
|
| Congenital Abnormalities | 2 | 1998 | 705 | 0.010 |
Why?
|
| Jejunum | 1 | 1985 | 471 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 2006 | 565 | 0.010 |
Why?
|
| Sertoli Cell Tumor | 1 | 1983 | 36 | 0.010 |
Why?
|
| Cytosine | 1 | 2004 | 211 | 0.010 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1983 | 67 | 0.010 |
Why?
|
| Guanine | 1 | 2004 | 277 | 0.010 |
Why?
|
| Pentetic Acid | 1 | 1983 | 209 | 0.010 |
Why?
|
| Technetium | 1 | 1983 | 321 | 0.010 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 1983 | 102 | 0.010 |
Why?
|
| Proline | 1 | 2004 | 456 | 0.010 |
Why?
|
| Genitalia, Female | 1 | 1983 | 147 | 0.010 |
Why?
|
| Algorithms | 2 | 2015 | 13952 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2003 | 256 | 0.010 |
Why?
|
| Urothelium | 1 | 2004 | 277 | 0.010 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2002 | 169 | 0.010 |
Why?
|
| Retreatment | 1 | 2003 | 599 | 0.010 |
Why?
|
| Alanine | 1 | 2004 | 593 | 0.010 |
Why?
|
| Postoperative Care | 2 | 1999 | 1473 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2846 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11028 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 974 | 0.010 |
Why?
|
| Linear Models | 2 | 2005 | 5863 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 11898 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1986 | 1200 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 590 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 692 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 2003 | 593 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5566 | 0 |